- Report
- November 2020
- 260 Pages
Global
From €2402EUR$2,750USD£2,086GBP
- Report
- November 2018
- 147 Pages
Global
From €2402EUR$2,750USD£2,086GBP
- Report
- September 2023
- 120 Pages
North America
From €5196EUR$5,950USD£4,514GBP
- Report
- October 2021
- 100 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- July 2024
- 150 Pages
Global
From €3275EUR$3,750USD£2,845GBP
- Report
- September 2024
- 145 Pages
Global
From €2619EUR$2,999USD£2,275GBP
- Report
- November 2024
- 74 Pages
From €3013EUR$3,450USD£2,617GBP
- Report
- March 2022
- 180 Pages
Global
From €3144EUR$3,600USD£2,731GBP
- Report
- June 2025
- 250 Pages
India
From €2436EUR$2,789USD£2,116GBP
- Report
- June 2025
- 250 Pages
Japan
From €2436EUR$2,789USD£2,116GBP
- Report
- February 2024
- 103 Pages
Global
From €3500EUR$4,293USD£3,147GBP
- Report
- September 2025
- 50 Pages
Global
From €2314EUR$2,650USD£2,010GBP
Hydrocodone is an opioid analgesic medication used to treat moderate to severe pain. It is a semi-synthetic opioid derived from codeine and is available in both immediate-release and extended-release formulations. Hydrocodone is commonly prescribed for the treatment of pain associated with surgery, trauma, and chronic conditions such as cancer and arthritis. It is also used to treat coughs and other respiratory conditions. Hydrocodone is often combined with other medications, such as acetaminophen or ibuprofen, to increase its effectiveness.
Hydrocodone is one of the most widely prescribed analgesics in the United States. It is available in both generic and brand-name formulations, and is often prescribed in combination with other medications. The use of hydrocodone has been increasing in recent years, due to its effectiveness in treating pain and its availability in generic formulations.
Some of the companies in the hydrocodone market include Purdue Pharma, Endo Pharmaceuticals, Teva Pharmaceuticals, and Mylan Pharmaceuticals. Show Less Read more
